Myocene develops a portable device that utilizes electro-stimulation and force sensing technology to accurately measure muscle fatigue in athletes. This precise assessment enables better training management, reducing the risk of overtraining and injury while enhancing athletic performance.
Funding
$3.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for assessing muscle fatigue in athletes often lack precision and portability, hindering effective training management and increasing the risk of overtraining and injury. Traditional lab-based assessments are not easily accessible in the field, limiting real-time monitoring and personalized training adjustments.
Solution
Myocene offers a portable device that combines electro-stimulation and force-sensing technology to provide objective measurements of muscle fatigue in athletes. The device quantifies the force drop associated with fatigue, delivering a fatigue index within two minutes. This enables coaches and athletes to monitor fatigue levels, optimize training regimens, and reduce the risk of injuries. The technology is validated by key opinion leaders and is supported by scientific research, making it a reliable tool for assessing muscular fatigability in the field.
Target Audience
The primary target audience includes athletes, coaches, and sports medicine professionals seeking precise and portable tools for monitoring muscle fatigue to optimize training and reduce injury risk.
Features
- Portable device for on-field muscle fatigue assessment
- Combines electro-stimulation and force-sensing technologies
- Provides a fatigue index in two minutes
- Patented high-precision control of muscle contraction
- Proprietary algorithm and AI for accurate measurements
- Ultra-high sensitivity sensor
- FDA authorized for objective measures of muscle fatigue